Cargando…

Efficacy and Safety of the New Appetite Suppressant, Liraglutide: A Meta-Analysis of Randomized Controlled Trials

BACKGROUND: Obesity is a chronic disease associated with metabolic diseases such as diabetes and cardiovascular disease. Since the U.S. Food and Drug Administration approved liraglutide as an anti-obesity drug for nondiabetic patients in 2014, it has been widely used for weight control in overweight...

Descripción completa

Detalles Bibliográficos
Autores principales:	Moon, Shinje, Lee, Jibeom, Chung, Hye Soo, Kim, Yoon Jung, Yu, Jae Myung, Yu, Sung Hoon, Oh, Chang-Myung
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Korean Endocrine Society 2021
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8258332/ https://www.ncbi.nlm.nih.gov/pubmed/34139800 http://dx.doi.org/10.3803/EnM.2020.934

Ejemplares similares

Efficacy and Safety of Insulin Degludec/Insulin Aspart Compared with a Conventional Premixed Insulin or Basal Insulin: A Meta-Analysis
por: Moon, Shinje, et al.
Publicado: (2021)

Implication of diet and exercise on the management of age‐related sarcopenic obesity in Asians
por: Kim, Yoon Jung, et al.
Publicado: (2022)

Beneficial Effects of Time-Restricted Eating on Metabolic Diseases: A Systemic Review and Meta-Analysis
por: Moon, Shinje, et al.
Publicado: (2020)

Z-score of the log-transformed A Body Shape Index predicts low muscle mass in population with abdominal obesity: The U.S. and Korea National Health and Nutrition Examination Survey
por: Moon, Shinje, et al.
Publicado: (2020)

Effect of body shape on the development of cardiovascular disease in individuals with metabolically healthy obesity
por: Oh, Chang-Myung, et al.
Publicado: (2020)

The impact of urinary incontinence on falls: A systematic review and meta-analysis
por: Moon, Shinje, et al.
Publicado: (2021)

SAT-173 Antiproliferative Effect of Teneligliptin on Atherosclerosis in Vascular Smooth Muscle Cell
por: Moon, Shinje, et al.
Publicado: (2019)

Association between body shape index and risk of mortality in the United States
por: Lee, Heysoo, et al.
Publicado: (2022)

Utility of the Z-score of log-transformed A Body Shape Index (LBSIZ) in the assessment for sarcopenic obesity and cardiovascular disease risk in the United States
por: Chung, Wankyo, et al.
Publicado: (2019)

The Association between Z-Score of Log-Transformed A Body Shape Index and Cardiovascular Disease in Korea
por: Chung, Wankyo, et al.
Publicado: (2019)

Smoking and passive smoking increases mortality through mediation effect of cadmium exposure in the United States
por: Kim, Joon, et al.
Publicado: (2023)

Analyzing the Factors Associated With Nocturia in Older People in the United States
por: Kim, Joo Seop, et al.
Publicado: (2018)

Associations between Hashimoto Thyroiditis and Clinical Outcomes of Papillary Thyroid Cancer: A Meta-Analysis of Observational Studies
por: Moon, Shinje, et al.
Publicado: (2018)

The Relationship Between Nocturia and Mortality: Data From the National Health and Nutrition Examination Survey
por: Moon, Shinje, et al.
Publicado: (2022)

Association between Serum Selenium Level and the Presence of Diabetes Mellitus: A Meta-Analysis of Observational Studies
por: Kim, Juno, et al.
Publicado: (2019)

The Association Between Obesity and the Nocturia in the U.S. Population
por: Moon, Shinje, et al.
Publicado: (2019)

Efficacy and safety of liraglutide in Indian adolescents with obesity
por: Kochar, I. S., et al.
Publicado: (2019)

Assessment HOMA as a predictor for new onset diabetes mellitus and diabetic complications in non-diabetic adults: a KoGES prospective cohort study
por: Lee, Jibeom, et al.
Publicado: (2023)

Response: Association of Z-Score of the Log-Transformed A Body Shape Index with Cardiovascular Disease in People Who Are Obese but Metabolically Healthy: The Korea National Health and Nutrition Examination Survey 2007–2010 (J Obes Metab Syndr 2018;27:158–65)
por: Chung, Wankyo, et al.
Publicado: (2019)

Association of Z-Score of the Log-Transformed A Body Shape Index with Cardiovascular Disease in People Who Are Obese but Metabolically Healthy: The Korea National Health and Nutrition Examination Survey 2007–2010
por: Chung, Wankyo, et al.
Publicado: (2018)

The influence of physical activity on risk of cardiovascular disease in people who are obese but metabolically healthy
por: Moon, Shinje, et al.
Publicado: (2017)

The efficacy and safety of liraglutide in the obese, non-diabetic individuals: a systematic review and meta-analysis
por: Zhang, Pei, et al.
Publicado: (2019)

Berberine for Appetite Suppressant and Prevention of Obesity
por: Park, Hyun-Jung, et al.
Publicado: (2020)

Effects of Liraglutide on Appetite, Food Preoccupation, and Food Liking: Results of a Randomized Controlled Trial
por: Tronieri, Jena Shaw, et al.
Publicado: (2019)

Pharmacology, efficacy and safety of liraglutide in the management of type 2 diabetes
por: Neumiller, Joshua J, et al.
Publicado: (2010)

Development and validation of a new diabetes index for the risk classification of present and new-onset diabetes: multicohort study
por: Moon, Shinje, et al.
Publicado: (2021)

Synergistic interaction between prolonged increased glycemic exposure and mildly increased urinary albumin excretion on diabetic retinopathy
por: Moon, Shinje, et al.
Publicado: (2018)

Liraglutide Modulates Appetite and Body Weight Through Glucagon-Like Peptide 1 Receptor–Expressing Glutamatergic Neurons
por: Adams, Jessica M., et al.
Publicado: (2018)

Exploring the Genetic Associations Between the Use of Statins and Alzheimer's Disease
por: Lee, Jibeom, et al.
Publicado: (2022)

Pharmacologic Activation of Angiotensin-Converting Enzyme II Alleviates Diabetic Cardiomyopathy in db/db Mice by Reducing Reactive Oxidative Stress
por: Kim, Donghyun, et al.
Publicado: (2023)

The Cut-off Values of Surrogate Measures for Insulin Sensitivity in a Healthy Population in Korea according to the Korean National Health and Nutrition Examination Survey (KNHANES) 2007–2010
por: Moon, Shinje, et al.
Publicado: (2018)

Visit-to-visit HbA1c and glucose variability and the risks of macrovascular and microvascular events in the general population
por: Jang, Ji-Yong, et al.
Publicado: (2019)

The effects of a GLP-1 analogue liraglutide on reward value and the learned inhibition of appetitive behavior in male and female rats
por: Jones, Sabrina, et al.
Publicado: (2018)

Integrated analysis of the microbiota-gut-brain axis in response to sleep deprivation and diet-induced obesity
por: Lee, Jibeom, et al.
Publicado: (2023)

Appetite suppressants and valvular heart disease – a systematic review
por: Loke, Yoon K, et al.
Publicado: (2002)

The efficacy and safety of liraglutide added to metformin in patients with diabetes: a meta-analysis of randomized controlled trials
por: Gu, Jianqiu, et al.
Publicado: (2016)

Liraglutide in Adults with Type 2 Diabetes: Global Perspective on Safety, Efficacy and Patient Preference
por: Yabe, Daisuke, et al.
Publicado: (2011)

Efficacy and safety of liraglutide added to insulin therapy in elderly patients with type 2 diabetes
por: Tonoike, Mie, et al.
Publicado: (2018)

Efficacy and Safety Comparison of Liraglutide, Glimepiride, and Placebo, All in Combination With Metformin, in Type 2 Diabetes: The LEAD (Liraglutide Effect and Action in Diabetes)-2 study
por: Nauck, Michael, et al.
Publicado: (2009)

Meta-analysis of the efficacy of liraglutide in patients with type 2 diabetes accompanied by incipient nephropathy
por: Liu, Wei, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_jrrsr7l473tgenjjupfih86bgl